Antagonist Of The Fibroblast Growth Factor Receptor 3 (Fgfr3) For Use In The Treatment Or The Prevention Of Skeletal Disorders Linked With Abnormal Activation Of Fgfr3 - EP2790718

The patent EP2790718 was granted to Assistance Publique Hpitaux DE Paris on Feb 7, 2018. The application was originally filed on Dec 12, 2012 under application number EP12799204A. The patent is currently recorded with a legal status of "No Opposition Filed Within Time Limit".

EP2790718

ASSISTANCE PUBLIQUE HPITAUX DE PARIS
Application Number
EP12799204A
Filing Date
Dec 12, 2012
Status
No Opposition Filed Within Time Limit
Dec 14, 2018
Publication Date
Feb 7, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents